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It has been  generally accepted  that  neonatal  animals  are more susceptible  to the 
induction of immunological tolerance than adults. This concept was originally based 
upon  studies  of intact  animals  performed  before  the  realization  that  a  number  of 
interacting  cells  are  involved  in  immune  responses,  any of which  may serve  as  the 
target for tolerance induction  (1-3).  More recently, this enhanced neonatal suscepti- 
bility  to  tolerogenesis  in  humoral  immunity  has  been  studied  at  the  cellular  level. 
Although initially thought to be a  result of increased suppressor thymic-derived (T) 1 
cell activity in neonatal spleens  (4), this heightened susceptibility to tolerance induc- 
tion was recently shown to reside in neonatal B lymphocytes (5-8). 
Studies  of the  ontogeny of the  bone marrow  (bursal  equivalent)-derived  (B)  cell 
response to thymic independent  (TI) antigens have led to the classification of B cells 
into two functional categories  (9). Neonatal  B cells respond to TI-1 antigens  (such as 
trinitrophenylated  lipopolysaccharide, TNP-LPS)  and to the mitogen, LPS, but  are 
refractory to stimulation by TI-2 antigens (like TNP-FicoI1) and the mitogen, purified 
protein  derivative  (PPD)  (9,  10).  B  lymphocytes from adult  mice, however, respond 
to all of these  agents.  Supporting  the division  of B  lymphocytes into mature,  adult 
type  (TI-2)  and  immature,  neonatal-type  (TI-1)  B  cells  is  the  responsiveness  and 
lymphocyte constitution of the CBA/N mouse (9,  10).  Bearing an x-linked  defect in 
responses  to TI antigens  (11),  CBA/N  mice exhibit  a  decreased  number  of surface 
immunoglobulin (sIg)-bearing lymphocytes (12) and sIg and/x densities (13) suggestive 
of a deficit of mature B lymphocytes. Mice bearing this defect react to stimulation by 
TI-I  antigens  and  the  mitogen,  LPS  (9,  10).  However,  they are  unreactive  to TI-2 
antigens and are markedly hyporesponsive to mitogenic stimulation  by PPD  (9,  10). 
Thus, responses elicited by TI-1 or TI-2 antigens, or nonspecific polyclonal activators 
are  characteristic  of the  maturation  level of the  B  cells  involved,  and  may then  be 
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used  to  functionally  identify  the  state  of  maturity  of  the  reactive  B-lymphocyte 
subpopulations. 
In this communication, the maturity of B cells involved in the induction of tolerance 
by  trinitrobenzenesulfonic  acid  (TNBS)  (14-16)  was  investigated.  The  maturation 
level of the B  cells being studied was defined by the antigen or polyclonal activator 
which elicited a response. Thus, the magnitude of the hapten-specific response induced 
by TI- 1 or TI-2 antigens, or the number of TNP-specific plaque-forming cells (PFC) 
resulting  from  stimulation  by  polyclonal activators  was  used  as  a  measure  of the 
tolerogenic effect  of TNBS  injection  upon  either  the  mature  adult-type  (TI-2)  or 
immature  neonatal-type  (TI-1)  B  cells of the  adult spleen.  Tolerance  to  TNP  was 
induced  more  rapidly  after  TNBS  injection  in  immature  than  in  mature  B  cells. 
Moreover, a lower dose of tolerogen was required to induce a state of unresponsiveness 
in  neonatal-type  than  in  adult-type  B  cells.  These  results  support  the  concept  of 
differential tolerance susceptibility in two subpopulations ofB lymphocytes present in 
adult spleen, the immature neonatal-type B  cells exhibiting heightened susceptibility 
in comparison with the mature adult-type B  lymphocytes. 
Materials  and  Methods 
Mice.  Male CBA/CaJ  mice  were  obtained  from  The Jackson  Laboratory, Bar  Harbor, 
Maine, or were bred at the Scripps Clinic and Research Foundation, La Jolla, Calif. All mice 
were used at 8-12 wk of age and were generally the same age within an experiment. 
Antigens and Polyclonal Activators.  The preparation, storage, and use of TNP-LPS (nine TNP 
residues per  100,000  daltons of LPS)  were as described previously (17).  4-hydroxy-3-iodo-5- 
nitrophenylacetic acid (NIP)-LPS (11 NIP residues per 100,000  daltons of LPS) was prepared 
by mixing 25 mg of LPS and 20 mg of NIP-azide in 0.1 M  bicarbonate buffer for 12 h at 4°C 
with constant stirring. After extensive dialysis against phosphate-buffered saline, the conjugate 
was stored at  -20°C.  LPS, prepared from Escherichia  coli 011 l:B4 by the trichloroacetic acid 
(Boivin) extraction procedure, was purchased  from Difco Laboratories, Detroit, Mich. TNP 
was conjugated to Ficoll (TNP-Ficoil, 68 mol TNP/mol of Ficoll) as described previously (18) 
using Ficoll 400 (Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N. J.). The 
immunizing dose of TNP-LPS, NIP-LPS, and TNP-Ficoll was 10 ng/l ml culture of 10  ×  106 
viable spleen cells. PPD,  extracted from  Mycobacterium  tuberculosis  RT33,  was  obtained  from 
Statens Seruminstitut, Copenhagen,  Denmark. Sheep erythrocytes (SRC)  and horse erythro- 
cytes (HRC) were obtained in Alsever's solution from the Colorado Serum Co., Denver, Colo., 
and from a single sheep and horse maintained by the Scripps Clinic and Research Foundation. 
HRC  were heavily conjugated with TNP  (TNP-HRC)  essentially as described by Kettman 
and  Dutton  (19),  whereas the method  of Rittenberg and  Pratt  was used  for preparation of 
lightly conjugated TNP-HRC  (20). 
Tolerogen.  Tolerance to TNP was induced in vivo by the i.p. injection of TNBS  (Eastman 
Kodak Co., Rochester, N. Y.) prepared by dissolving 100 mg of TNBS and 28.65  mg of Na- 
HCO~ in  10 ml of 0.15  M  NaCI  (14,  21). The tolerogen was administered by injection of 0.5 
ml/mouse of this TNBS solution or dilutions thereof in saline. 
Tissue  Culture.  Single cell suspensions were  prepared as previously described  (22,  23)  in 
balanced  salt  solution  (BSS)  buffered  with  Hepes  (Calbiochem-Behring  Corp.,  American 
Hoechst Corp., San Diego, Calif.), isoosmotic with mouse serum  (308  mosmol, equivalent to 
0.168  M  NaCl)  (22,  24), and containing 10% fetal calf serum  (FCS, Grand Island Biological 
Co., Grand Island, N. Y.)  (BSS-FCS). The cells were resuspended and cultured in serum-free 
medium consisting of: RPMI-1640 medium made from powder (Grand Island Biological Co.) 
to be isoosmotic with mouse serum, 0.034% NaHCO3, 0.2 mM glutamine, and 0.95 mM sodium 
pyruvate (all Microbiological Associates, Walkersville, Md.),  100 U/ml penicillin (Eli Lilly & 
Co., Indianapolis, Ind.), 100 ~g/ml streptomycin (Eli Lilly & Co.), and  10 mM Hepes. 
A modification of the Mishell-Dutton culture system (25) was used as described previously 
(16).  Plastic tissue culture trays  (3008,  Falcon Labware, Div.  of Becton,  Dickinson, &  Co., JOHN M.  FIDLER  493 
Oxnard, Calif.) were used to culture 10 ×  l0  s viable spleen cells in 1 ml of medium. Cells were 
prepared so that 0.9 ml of cell suspension was added per culture, which was then supplemented 
with 0.1  ml of antigen or polyclonal  activator in medium.  All experiments  included  cultures 
receiving medium only to serve as background controls. 
In some cases, spleen cells were incubated without the addition of antigen for 24 h, followed 
by washing three times and the addition of antigen upon reculturing  (16). 
Assay of Antibody-Forming Cells.  Direct anti-SRC, anti-TNP, and anti-NIP PFC were assayed 
by a  modification  of the Cunningham plaque technique  as described  previously  (17, 23, 26, 
27).  High  affinity  TNP-specific  PFC  were  assayed  using  lightly  coupled  TNP-HRC  and 
subtracting the PFC produced against unconjugated HRC. The low affinity TNP-specific PFC 
response was determined  using heavily conjugated TNP-HRC and subtracting the anti-HRC 
and high affinity anti-TNP responses. 
Results 
Kinetics of TNBS Tolerance.  It was demonstrated previously that spleen cells  from 
mice given 5 mg of TNBS 4 d earlier are specifically tolerant to the TNP hapten in 
response to immunogenic challenge with TI and thymic-dependent (TD) forms of the 
hapten in vivo and in vitro (14-16, 28). Although it has been suggested that hapten- 
specific B-cell unresponsiveness in systems similar to this is maintained by blocking of 
sIg molecules by tolerogen (29, 30), receptor blockade is clearly not responsible for the 
maintenance of tolerance in this system. Functional deletion of TNP-specific B cells 
appears  to be  the  mode of TNBS-induced tolerance.  Examination  at  shorter  time 
intervals after the tolerizing injection was undertaken  to obtain information on the 
induction phase of tolerance. Accordingly, spleen cells from mice injected with TNBS 
at one of a series  of intervals before sacrifice were placed in vitro with TNP-LPS and 
NIP-LPS. As shown in Fig.  1, unresponsiveness to TNP was rapidly induced with the 
TNP-specific  responsiveness  being  reduced  by  89%  1  h  after  TNBS  injection.  A 
plateau  level  of virtually complete tolerance was obtained by  12  h  after  tolerogen 
administration which persisted through day 4 as shown previously (16).  Responses to 
the control NIP hapten were not reduced by TNBS administration. 
Cocuttures of Tolerant and Normal Cells.  To investigate the carryover of tolerogen by 
TNBS-treated spleen cells which might inhibit the response of, or induce tolerance in, 
other splenocytes, a cell mixing experiment was conducted with spleen cells  from the 
experiments shown above. Spleen cells from mice injected with the TNBS from 1 h to 
4  d  before sacrifice were  cultured  with  equal  numbers  of untreated  control spleen 
cells.  Based upon the results obtained in the above experiment  (Fig.  1), any effect of 
one  preparation  upon  the  other  cell  population  could  be  assessed.  There  was  no 
significant reduction in the anti-NIP response of control splenocytes by tolerant spleen 
cells  (Fig.  2).  The  1-h  TNBS-treated  group  reduced  the  anti-TNP  response of the 
control cells such that only 3% of the expected PFC resulted.  At  12 h, the reduction 
was  36%,  and  there  appeared  to  be  no significant  decrease  past  this  point.  These 
results suggest that a large measure of the reduction in response observed with the  1- 
h group and part of that with the 12-h group may be a result of suppression mediated 
in  vitro.  The  suppression  could  result  from  the  elution  of sIg-bound  blockading 
moieties and binding to and inhibition of the response of other TNP-specific lympho- 
cytes. 
Antigen-Free Incubation of Unrespomive Cells.  The concept of receptor blockade as the 
cause of hapten-specific unresponsiveness was supported in experiments of Gronowicz 
and Coutinho (29) and Aldo-Benson and Borel (30) in which antigen-free cultivation 494  DIFFERENTIAL TOLERANCE  SUSCEPTIBILITY IN  ADULT  B-CELL  SUBSETS 
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Fzc.  l.  Kinetics of TNBS tolerance assessed  in vitro.  Spleen cells  from mice either injected  i.p. 
with 5 mg of TNBS in 0.5 ml of saline at one of a series of intervals before sacrifice or left untreated 
were placed in culture with l0 ng of TNP-LPS and  10 ng of NIP-LPS. Cultures were harvested for 
assay on day 2. Values represent anti-NIP and anti-TNP PFC/culture  +  SE of three cultures per 
group assayed  individually.  Data  from  four experiments are  pooled.  Background  responses are 
subtracted. Abscissa, interval between TNBS injection and in vitro culture; ordinate, anti-NIP and 
anti-TNP PFC/culture. 
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FIC.  2.  Coculture of TNBS-treated  and control spleen cells.  Spleen cells  from mice injected  i.p. 
with 5 mg of TNBS in 0.5 ml of saline at one of a number of intervals before sacrifice were cultured 
together with spleen cells  from untreated mice  (5  ×  106  viable cells  of each  type/l  ml culture). 
Cultures received  10 ng of TNP-LPS and  10 ng of NIP-LPS and were harvested for assay on day 2. 
Values represent anti-NIP and anti-TNP PFC/culture  +  SE of three cultures per group assayed 
individually.  Data are  pooled from four experiments. Background responses are subtracted.  The 
expected  response is  the  number of PFC  that  would  be  obtained  if no  interaction  of either  a 
suppressing or enhancing nature took place between the two types of spleen cells.  The observed 
response ziz  SE and the expected response in terms of anti-NIP PFC/culture were as follows:  TNBS 
day 4:1026  +  82  (977);  TNBS day 2:920  1  39 (868);  TNBS day  1:883  -  52  (901);  TNBS 12 h: 
787  +  33 (937);  and TNBS 1 h: 953  +  5l  (891). Abscissa, interval between TNBS injection and in 
vitro culture; ordinate, expected and observed anti-TNP PFC/cuhure. O, calculated  response; O, 
observed response. y 
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FIG. 3.  Effect  of antigen-free culture on TNBS tolerance. Spleen cells from mice either injected 
i.p. with 5 mg of TNBS in 0.5 ml of saline at one of a series of intervals before sacrifice or left 
untreated were placed in culture without antigen. After 24 h, the cultures were harvested, pooled 
within  groups, and washed three times by dilution  with  BSS-FCS followed by centrifugation 
through FCS. After washing, the cells were diluted in medium and cultured with 10 ng of TNP- 
LPS and 10 ng of NIP-LPS per culture. All cultures were harvested for assay 2 d after the addition 
of antigen. Values represent anti-NIP and anti-TNP PFC per culture  ±  SE of three cultures per 
group assayed individually. Data  are pooled from four experiments. Background responses are 
subtracted. The anti-NIP PFC/culture  responses were: TNBS day 4:910 ±  85; TNBS day 2:696 
±  27; TNBS day 1:1012 --- 41; TNBS 12 h: 900 ±  79; TNBS 1 h: 817 ±  34; and no TNBS: 928 
±  53. O, normal; O, preincubation for 24 h. 
was successful in reversing an apparent tolerant state. Although shown previously to 
be ineffective in breaking tolerance 4 d  after TNBS injection, it was possible that the 
early stages of unresponsiveness could be reversed by such a  maneuver. 
To further investigate this point, the effect of 24-h antigen-free incubation of spleen 
cells from  TNBS-injected mice,  followed by extensive washing and challenge with 
antigen,  was  tested.  The  results  of  this  experiment  using  spleen  cells  from  the 
experiments described above are shown in Fig.  3.  Confirming previous results  (16), 
tolerance in the cultures of the day 4  group was  not  reversed by 24-h antigen-free 
incubation. Spleen ceils from  the  mice sacrificed  1 h  after tolerogen injection gave 
55% of the control level TNP-specific response after the 24-h cultivation period. By 12 
h  after TNBS administration, however, there was no longer any significant recovery 
from TNBS-induced tolerance effected  by antigen-free culture. Thus, in the period 
between  1 and  12 h  after TNBS injection, during which splenocytes were losing the 
capacity to inhibit the response of other cells, the tolerance reached a  stage where it 
could not be reversed by antigen-free incubation. Furthermore, tolerance induced by 
TNBS and assessed in vitro is initially characterized by a partially reversible blockade, 
and suggests that tolerogen carryover is responsible. 
TNBS Tolerance and the  TNP-FicoU Response.  Based upon an analysis of the matu- 
ration state of cells responding to TI antigens, it has been suggested that  the B cells 
reactive with TNP-LPS (a TI-1 antigen) are less mature than B lymphocytes respond- 
ing to  a  number of other  TI  antigens (9).  To  extend  the  above observations, the 
antigen-specific response to a TI antigen stimulating a  more mature subset of B cells 
was investigated. 
The TI-2 antigen TNP-Ficoll was used in an experiment identical to those shown 496  DIFFERENTIAL TOLERANCE  SUSCEPTIBILITY IN ADULT  B-CELL SUBSETS 
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Fzc.  4.  Kinetics of TNBS tolerance: challenge with TNP-Ficoll in vitro. Information is identical 
to Fig. 1 except that TNP-Ficoll was utilized rather than TNP-LPS. The anti-NIP PFC per culture 
responses were: TNBS day 4:777 ±  26; TNBS day 2:810 ±  33; TNBS day 1:880 -+ 53; TNBS 
12 h: 986 +  27; TNBS 1 h: 829 ±  36; and no TNBS: 760 +  29. Data from two experiments are 
pooled. Q), TNP-LPS; O, TNP-Ficoll. 
in Figs.  1-3.  Thus, spleens from  mice injected with TNBS  at  one of a  number of 
intervals earlier were placed in culture with TNP-Ficoll. As shown in Fig. 4, complete 
tolerance was evident when cells were cultured 1, 2, and 4 d after the TNBS injection. 
When examined 1 or  12 h  after tolerogen treatment, tolerance was incomplete with 
28  and 20% of the control response obtained, respectively. This compares to an  11 
and 2% response at the 1- and 12-h points with TNP-LPS challenge. Thus, it appears 
that complete unresponsiveness to TNP was induced earlier in B cells responding to 
TNP-LPS  than to  TNP-Ficoll. This  further suggests  that  TNBS  induces tolerance 
more rapidly in those immature cells which are responsive to a TI-1 antigen than in 
the more mature cells reactive with a TI-2 antigen. 
Coculture and the TNP-Ficoll Response.  To further investigate the response to TNP- 
Ficoll  of  TNBS-treated  spleen  cells,  tolerant  splenocytes  were  cultured  in  equal 
numbers with spleen cells from untreated mice. There was little or no reduction of the 
control anti-TNP response by the cells from mice treated with TNBS  1,  2, and 4  d 
earlier  (Fig.  5).  The only group causing significant reduction in the  response from 
untreated spleen cells received TNBS  1 h  before culture where a  60% reduction was 
evident. This result may be compared to the 97 and 36% reduction in the response to 
TNP-LPS caused by the  1 and 12 h  groups, respectively. Thus, the response to TNP- 
Ficoll by control cells was inhibitable for a shorter time and to a lesser extent by cells 
from tolerant mice than the response to TNP-LPS. 
Antigen-Free Culture and the TNP-Ficoll Response.  The effect of 24 h of antigen-free in 
vitro  cultivation upon  the  PFC  response  to  TNP-Ficoll was  next  investigated. As 
shown in Fig. 6, this incubation did not reverse the state of unresponsiveness induced 
by TNBS injection. Essentially the same level of response was obtained after a  24-h 
cultivation of TNBS-treated spleen cells as exhibited by splenocytes challenged with 
antigen at the initiation of culture (Fig. 4). Tolerance was maintained in the 2- and 
4-d groups, whereas an anti-TNP PFC response of 38, 20, and 18% of the control level 
was  induced by TNP-Ficoll in spleen cells from  mice given TNBS  1,  12,  and 24 h 
before culture, respectively. These results suggest  that TNP-Ficoll-reactive (TI-2) B JOHN  M.  FIDLER  497 
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FIG.  5.  Coculture  of TNBS-treated  and  control  spleen  cells:  response to  TNP-Ficoll  in  vitro. 
Information  is identical  to  Fig.  2  except  that  TNP-Ficoll  was  used in  place of TNP-LPS.  The 
observed response  ±  SE  and  the expected  response in  terms of anti-NIP  PFC/culture  were as 
follows: TNBS day 4:884  ±  45 (769); TNBS day 2:796 :t:  33 (785); TNBS day 1:882  ±  38 (773); 
TNBS 12 h: 753 ±  38 (873); and TNBS 1 h: 914 ±  45 (794). Data are pooled from two experiments. 
O, calculated response; O, observed response. 
lymphocytes are  less  susceptible  to  the  blockade  that  occurs early  after  tolerogen 
injection and require a longer period of time for the induction of tolerance than TI-1 
B cells responsive to TNP-LPS. 
Polyclonal Activation and TNBS Tolerance Kinetics.  The lack of TNP-specific response 
by splenocytes from mice treated  with  TNBS 4  d  before culture  to the polyclonal 
activator LPS was used  in  a  previous study to establish  functional  deletion  as  the 
mechanism of TNBS tolerance (16). To further investigate the induction of tolerance 
with  TNBS,  the  response  to  polyclonal B-cell  activation  of spleen  cells  from mice 
injected with TNBS 1 h to 4 d previously was determined. In addition to LPS which 
activates cells  in a  less mature B-lymphocyte subset, the mitogen PPD was used as a 
polyclonal activator of more mature B cells (10, 31).  HRC were conjugated lightly or 
heavily with  TNP  and  used  for  the  determination  of low and  high  affinity TNP- 
specific PFC as described in Materials and Methods. In all cases,  the PFC response to 
SRC induced by the polyclonal activator and used as a control for the hapten-specific 
effect of TNBS was relatively unchanged in the TNBS-treated groups (Fig.  7). The 
high affinity anti-TNP  PFC  induced  by LPS, which are  the same type assayed in 
specific anti-TNP responses, were not reduced by TNBS treatment  1 h  before tissue 
culture. By 12 h, the high affinity PFC were reduced 55% and reached a  low plateau 
level  of 4-12%  of the  control  level  response  1-4  d  after  TNBS  injection.  The  low 
affinity response was not greatly reduced (15 to 20% decrease) until 4 d  after TNBS 
administration when it was 44% of the control level. 
With PPD, the high affinity TNP response was at a high plateau level for 1 h to  1 
d after TNBS injection. On days 2 and 4, the response was reduced to  12-17% of the 
control level.  The low affinity response was stable at a high level from 1 h to 2 d after 
TNBS injection, with the response of cells taken 4 d  after tolerogen administration 
dropping to 40%  of the control level.  A  number of conclusions may be drawn from 
these data:  (a)  there is a  greater effect of the tolerogen upon the production of high 
affinity  than  low affinity PFC,  suggesting that  the  precursor  B  cells  bearing high 498  DIFFERENTIAL TOLERANCE  SUSCEPTIBILITY IN ADULT B-CELL  SUBSETS 
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Fla. 6.  Effect of antigen-free culture on TNBS  tolerance:  TNP-Ficoll  response. Information  is 
identical to Fig. 3 except that TNP-Ficoll was used in place of TNP-LPS.  The anti-NIP PFC per 
culture response was: TNBS day 4:897  ±  53; TNBS day 2:937  +  39; TNBS day 1:915  ±  41; 
TNBS  12 h: 958  ±  56; TNBS  l h: 862  +  39; and no TNBS: 884 ±  47. Data are pooled from two 
experiments. O, normal; 0, pre-incubation  for 24 h. 
affinity TNP-specific receptors are more susceptible to tolerogenesis than those bearing 
receptors of low  affinity.  (b)  There  is  a  kinetic  difference in  the effect  of tolerogen 
upon  the  PFC  of the  two  affinity  classes  with  low  affinity  precursor  cells  being 
tolerized more rapidly than high affinity B cells. (c) The magnitude of the polyclonal 
B-cell  response  of control  cells  to  PPD  is  greater  than  that  to  LPS.  (d)  The  high 
affinity PFC produced in response to LPS were reduced earlier after TNBS  injection 
than the response induced by PPD  (12 h  vs. 2 d), suggesting that the less mature cells 
responding to LPS are susceptible earlier to a greater extent to the tolerance-inducing 
activity of TNBS than the more mature B cells responding to PPD.  (e) Conversely, no 
significant difference in the susceptibility to tolerance of the low affinity PFC response 
to these polyclonal B-cell activating substances was detected. 
TNBS Dose Response Curve and Polyclonal Activation.  Another approach to the inves- 
tigation of the cell populations involved in hapten-specific tolerogenesis is the deter- 
mination  of the  tolerance  dose-response relationship.  The  possibility of differential 
tolerance on a  subpopulation basis was tested using polyclonal B-cell activation with 
LPS and  PPD  as shown  above. Spleen cells were cultured  2  d  after the donor mice 
received one of a  series of TNBS doses because complete tolerance in the high affinity 
LPS  and  PPD  responses was  first  attained  at  this  time.  As  noted  in  Fig. 8,  TNBS 
injection caused essentially no reduction in anti-SRC responses induced by LPS and 
PPD. The high affinity PFC produced in response to LPS were reduced 26 and  76% 
by the two lowest TNBS doses (0.01 and 0.1 rag, respectively) with a low plateau level 
of 4-10%  in  the  control  response  remaining  at  the  three  highest  doses.  The  high 
affinity TNP-specific response  induced  by PPD  was  much  more resistant  to  tolero- 
genesis by TNBS,  with  63-81%  of the  response remaining at  0.1-2.5  mg of TNBS 
injected and 84% tolerance finally being achieved at the 5-mg dose. When calculated 
in  terms of the percentage of control high  affinity response, the 50%  tolerance level 
was  achieved  at  a  100-fold  lower  dose  of TNBS  for  LPS  than  for  PPD.  Thus,  in 
addition  to  the  kinetics of TNBS-induced  tolerance  being  dissimilar for  LPS-  and 
PPD-responsive  cell  populations,  the  dose-response relationship  also  differed.  LPS- JOHN  M.  FIDLER  499 
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FIG.  7.  Polyclonal activation and kinetics of TNBS tolerance. Spleen cells taken from mice injected 
i.p. with 5 mg of TNBS in 0.5 ml of saline at various times previously were placed in tissue culture 
with  optimal  polyclonal  activating  concentrations  of  LPS  (50  ~tg/ml)  or  PPD  (250  p.g/ml). 
Uninjected mice served as controls. Assays were performed on day 3 of culture. Values represent 
high and  low  affinity anti-TNP  PFC/culture  ___  SE  in  groups of three cultures per experiment 
assayed individually. Data are pooled  from six separate experiments. The anti-SRC PFC/culture 
responses were:  LPS, TNBS day 4:170  ---  19; TNBS day 2:180  4-  21; TNBS day  1:197  ---  12; 
TNBS  12 h:  158  --.  2; TNBS  1 h: 210  ±  6; no TNBS:  180  ±  9; and PPD, TNBS day 4:311  ±  6; 
TNBS day 2: 303  ±  25;TNBSday  1:292  +  8;TNBS  12h:303  ±  26;TNBS  lh:349  ±  14; and 
no TNBS: 302  +  27. Abscissa, interval between TNBS injection and in vitro culture; ordinate, high 
and low affinity anti-TNP PFC/culture. O, LPS; 0, PPD. 
responsive (immature) B cells were tolerized at a significantly lower dose of tolerogen 
than the (more mature) PPD-reactive B cells. 
Affinity Differences  in Polyclonal Activation.  It is possible that differences in the affinity 
profiles of the TNP-specific PFC produced in response to LPS and PPD could account 
for  the  apparently  greater  susceptibility  of  LPS-reactive  TNP-specific  B  cells  to 
tolerance induction. This was tested using TNP-lysine inhibition of PFC produced by 500  DIFFERENTIAL  TOLERANCE  SUSCEPTIBILITY  IN  ADULT  B-CELL  SUBSETS 
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Fta.  8.  Polyclonal  activation  and the TNBS  dose response relationship.  Spleen  cells from mice 
given a  dose of TNBS ranging from 0.01  to 5 mg in 5 ml of saline were placed in culture 2 d  after 
the injection with the optimal polyclonal activating concentrations of LPS (50 #g/ml) or PPD (250 
#g/ml). Cultures were harvested for assay on day 3.  Values represent high and low affinity anti- 
TNP PFC/culture  +  SE in groups of three cultures per experiment assayed individually. Data are 
pooled  from  three  separate  experiments.  The  anti-SRC  PFC/cuhure  responses were:  LPS,  no 
TNBS:  110  4-  10;0.01  rag:  121  -1- 8;0.ling:  1t0  4- 4;  1.0mg:83 +  2; 2.5mg:80  4- 6; and5mg: 
110  4-  7; andPPD, noTNBS:323  +  16;0.01mg:405  4- 25;0. img:282  4-  11;  1.0mg:243  4-  15; 
2.5 rag:  267  4-  13; and 5 rag: 319  ±  17. Abscissa, dose of TNBS given to spleen donors; ordinate, 
high and low affinity anti-TNP PFC per culture. C), LPS; O, PPD. 
LPS and  PPD  stimulated  spleen  cells with  heavily conjugated  TNP-HRC.  A  defi- 
ciency in higher affinity PFC produced by stimulation with PPD would bias the data 
toward the result obtained above. This was not  the case  (data not  shown).  Thus,  a 
relative paucity of high affinity TNP-specific PFC is not responsible for the difference 
in tolerance induction observed between LPS- and PPD-reactive B cells. 
Discussion 
TNBS  induces  TNP-specific  unresponsiveness  when  tested  under  a  variety  of 
conditions (14-16, 28). When assessed in vitro, unresponsiveness was complete during 
the  1st  wk after TNBS  injection,  with  the TNP-LPS response rising to  26%  of the 
control level by 4 wk (16).  Closer scrutiny of the early portion of the time-course, as 
reported here, revealed that complete unresponsiveness was induced within  12 h after 
tolerogen treatment, with a small but significant response being obtained with spleen 
cells treated  1 h  before culture  (Fig.  1).  However, the partial  recovery of the TNP- 
LPS response of the 1-h group resulting from antigen-free incubation (Fig. 3) suggests 
that an initial  blockade of TNP-LPS reactive B ceils was caused by the injection of 
TNBS.  This  conclusion  is  supported  by the  results of the  coculturing  experiments JOHN M.  FIDLER  501 
(Fig.  2).  The anti-TNP response of normal cells was totally inhibited  by incubation 
with spleen cells from mice given TNBS 1 h earlier, although no reduction was caused 
by cells from mice receiving TNBS >12  h  earlier.  Partial elution  of the cell-bound 
blockading moiety apparently occurred  during  24 h  of culture  allowing a  response 
from spleen cells in the  1-h treated group to take place. Unresponsiveness in B cells 
tested early after tolerogen  treatment  is thus  maintained  by an  easily reversible or 
readily bypassed receptor blockade. The unresponsive state becomes well established 
as the tolerance becomes irreversible and leads to functional deletion of TNP-specific 
B  lymphocytes. It is unclear whether tolerant B  cells perish, or persist in an immu- 
nologically null  state.  In direct  contrast  to the  tolerance  models of Gronowicz and 
Coutinho  (29)  and Aldo-Benson  and  Borel  (30),  however,  receptor blockade  is  not 
responsible for the maintenance of TNBS tolerance. Whereas blockade is involved in 
the early events of tolerogenesis, functional deletion is responsible for B-cell tolerance 
induction by TNBS. 
The  maturation  level  of  the  B  cells  being  tolerized  by  TNBS  injection  was 
investigated using three separate approaches. Initially, the study involved the use of 
TNP-FicoI1, classified as a  TI-2 antigen  by Mosier et al.  (9)  on the basis of the late 
emergence of responsiveness during ontogeny and  the  lack of reactivity in CBA/N 
mice. The TI-1  antigen, TNP-LPS,  induces  responses at birth and  in CBA/N mice 
(9). The tempo of tolerance induction was demonstrably slower in the mature TI-2 B 
cells responding to TNP-Ficoll than in immature TNP-LPS-reactive B lymphocytes. 
Unlike  the result  with TNP-LPS,  24  h  of antigen-free culture  did  not  increase  the 
response to TNP-Ficoll. Furthermore, the PFC response to TNP-Ficoll of control cells 
was much less inhibitable by coculture with cells from TNBS-treated mice than was 
the TNP-LPS response, suggesting that  blockade contributed  little to the observed 
unresponsiveness  to  TNP-Ficoll.  Thus, judging  by the  effect  upon  responses  to TI 
antigens, immature TI-1 B cells were more susceptible to tolerogenesis by TNBS than 
more mature TI-2 B lymphocytes. In the second approach, the polyclonal response of 
tolerant  spleen  cells  was  studied  using  two  B-cell  activators  that  stimulate  cell 
populations differing in maturation level (10, 31).  It was concluded in a recent study 
of the ontogeny of B-cell mitogenesis that LPS activates immature B cells whereas the 
mitogen PPD stimulates predominantly mature B lymphocytes (10).  The response to 
PPD arose later than  that  to LPS in ontogeny and  in  the reconstitution  of lethally 
irradiated recipients by fetal liver stem cells (10, 31). Additionally, the unusually low 
PPD/LPS  response ratio of CBA/N  mice supports  this  conclusion  (10).  Tolerance 
was  induced  in  the  less  mature  TNP-specific  B  cells  responding  to  LPS  by  the 
production  of high  affinity antibody earlier  than  in  more mature,  PPD-reactive B 
lymphocytes. The third approach was the investigation of the dose-response relation- 
ship of tolerogenesis and reactivity to LPS and PPD. The immature B cells stimulated 
to high affinity TNP-specific antibody formation by LPS were rendered tolerant at a 
100-fold lower dose of TNBS  than the more mature PPD reactive B cells. Thus, by 
three  criteria,  the  immature  B  cells  in  the  spleen  prove to be  more susceptible  to 
tolerance induction with TNBS than the more mature B lymphocytes. 
Differences in  reactivity to a  hapten-specific tolerogen  were detected  using poly- 
clonal stimuli. It has been suggested by Coutinho  and Moiler (32,  33)  that  the only 
rigorous test of central B-cell tolerance is reactivity to nonantigen-specific polyclonal 
B-cell activators which  stimulate lymphocytes via non-Ig surface receptors.  Neither 502  DIFFERENTIAL TOLERANCE SUSCEPTIBILITY IN ADULT B-CELL SUBSETS 
LPS (16)  nor PPD could reverse the tolerance induced by TNBS injection 4 d before 
tissue culture. The distinction  between mature PPD-responsive and immature LPS- 
reactive populations appeared when kinetics and dose-response relationships of toler- 
ogenesis were studied.  A  much greater effect of the tolerogen was exerted upon the 
production of high affinity than low affinity TNP-specific PFC. This suggests that the 
precursors of PFC which bear low affinity TNP-specific receptors are more resistant 
to  the  tolerizing  effects of TNBS  injection  than  are  the  B  cells  with  high  affinity 
receptors,  as  would  be  predicted  by  cell  selection  theories  for  the  regulation  of 
antibody affinity (34).  In the studies which have supported this hypothesis  (35-37), 
an  antigen-specific  stimulus  was  used  to  test  the  state  of responsiveness,  thereby 
allowing  a  second  encounter  with  the  tolerated  determinant(s)  which  would  exert 
selective pressure  on  the  responding  cell  populations  (34).  Nonspecific stimulation 
with LPS and PPD was utilized  in the experiments reported here, allowing a  more 
direct  assessment of the immunoreactive potential of B  cells from tolerogen-treated 
mice without any preferential selection of affinity subsets by antigen. 
It is clear from in vitro (5-8) and in vivo (15)  experiments that neonatal B cells, in 
contrast to adult B lymphocytes, are very susceptible to tolerance induction. Although 
the differences in  resistance to tolerogenesis may be a  result of the maturation of B 
cells from/~ + •-  to bt + 8 +  lymphocytes (38-41), a conclusion which is supported by 
the effect of modulation  of B-receptors  (42-45),  a  number of other surface markers 
appear in  parallel with  the 8-surface receptor  (i.e., CR,  Ia, LyBs)  (41,  46-49).  The 
rate at which neonatal B cells acquire Ia is very similar to the rate that B cells from 
young mice lose susceptibility to tolerance induction  (5,  41).  Furthermore,  develop- 
ment  of susceptibility  to  inhibition  by anti-~  antiserum  correlates  to both  of these 
changes  (50-52).  The  late  acquisition  of immunocompetence  to  TNP-Ficoll  (9)  is 
temporally  related  to  the  appearance  of  these  surface  markers,  and  signals  the 
emergence of a  second B-cell subpopulation  (the mature, adult-type B lymphocyte). 
This conclusion  is supported by results with the CBA/N mouse.  In addition  to a 
number of other B-cell defects, mice of this strain exhibit an unusually low 8/~ ratio 
(13)  and cannot respond to TNP-Ficoll  (9).  Accordingly, these mice respond to TI-1 
antigens but lack B cells that  are reactive with TI-2 antigens  (9).  CBA/N mice are 
also  susceptible  to  hapten-specific  blockade  of  TD  responses  by  polysaccharide 
conjugates  (53,  54),  lack the  adult-type  mature  B-lymphocyte subpopulation,  and 
possess B cells which exhibit high levels of sIgM but apparently normal amounts of 
sIgD.  CBA/N  B  cells  are  similar  to  neonatal  B  lymphocytes  in  function,  surface 
antigens,  and  receptor display with  the  exception  of sIgD, which  is  present  in  the 
former but absent in the latter. Because B-cell neogenesis is continually underway in 
the  adult,  the  immature  B  cells,  apparently  identical  to  those  found  in  neonatal 
spleen, exist in the differentiation pathway as precursors of the mature adult  B cells 
which are absent  from the CBA/N mouse. The conversion from immature neonatal- 
type  to  mature  adult-type  B  cells  would  then  involve  acquisition  of the  differing 
reactivity patterns  and  surface  markers characteristic  of these cells.  Not  only do  B 
lymphocytes from different ontogenic levels differ in the profile of responsiveness to 
antigen-specific  and  nonspecific  stimuli  as  well  as  the  level  of  susceptibility  to 
tolerogenesis, but the data reported here show that both immature neonatal-type and 
mature adult-type B lymphocytes with these characteristics are present in adult mouse 
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Summary 
The  maturation  level  of the  B-lymphocyte subpopulations  involved  in  trinitro- 
phenyl (TNP)-specific immunological tolerance in adult mice induced by the injection 
oftrinitrobenzenesulfonic acid (TNBS) was investigated using in vitro antigen-specific 
and  nonspecific  polyclonal  stimulation.  The  maturity  of the  B-cell  subsets  being 
studied was defined by the antigen or polyclonal activator which evoked a  response. 
Thus,  the  thymic independent  (TI-1)  antigen  TNP-lipopolysaccharide (TNP-LPS) 
and the polyclonal stimulant  LPS were used to activate immature, neonatal-type B 
lymphocytes, whereas mature, aduh-type B cells were responsive to the TI-2 antigen, 
TNP-Ficoll, and the nonspecific activator, purified protein derivative (PPD). 
Whereas unresponsiveness in TNP-LPS-reactive (immature) B cells 4 d after TNBS 
treatment  was  previously  shown  to  be  the  result  of functional  deletion,  partially 
reversible receptor blockade was detected in this study early after tolerogen treatment. 
By  the  24-h  point,  tolerance  was  irreversible,  as  assessed  by  24-h  of antigen-free 
incubation and cocultivation of tolerant cells with control splenocytes. Tolerance was 
induced more rapidly in immature, TI-1 B cells  than in mature TI-2 B lymphocytes. 
B lymphocytes reactive to TNP-Ficoll were also less susceptible to receptor blockade. 
Using LPS as a nonspecific probe for immature B cells,  60% tolerance in high affinity 
TNP-specific  cells  was  induced  within  12  h  of TNBS  treatment,  and  complete 
unresponsiveness  by  24  h.  In  contrast,  no  significant  decrease  in  response  to  the 
mature B-cell activator, PPD, occurred until day 2.  Furthermore, the 50%  tolerance 
level was achieved in TNP-specific LPS-reactive B cells  by  100 times less tolerogen 
than required for PPD-responsive cells. 
Thus, TNBS-induced unresponsiveness  in cells  reactive to TNP-LPS is  initially a 
result  of reversible  receptor blockade which leads within  4 d  to functional deletion. 
Immature, TI-1 B lymphocytes, which give polyclonal responses to LPS and antigen- 
specific responses to TNP-LPS, are rendered tolerant  to TNBS more rapidly and at 
lower tolerogen doses  than  mature,  TI-2 mouse B  cells  which  react  polyclonally to 
PPD  and  specifically  to  TNP-Ficoll.  Moreover,  these  data  show  that  both  the 
immature and the mature B lymphocytes with these characteristic tolerance suscep- 
tibilities  and  specific and  nonspecific immune response patterns  are present  in  the 
adult mouse spleen. 
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